| Family Physicians Of Lima Inc | |
|
2875 W Elm St Lima OH 45805-2510 | |
| (419) 991-7805 | |
| (419) 991-7862 |
| Full Name | Family Physicians Of Lima Inc |
|---|---|
| Speciality | Family Medicine |
| Location | 2875 W Elm St, Lima, Ohio |
| Authorized Official Name and Position | Karri L Krendl (OWNER) |
| Authorized Official Contact | 4199917805 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Family Physicians Of Lima Inc 2875 W Elm St Lima OH 45805-2510 Ph: (419) 991-7805 | Family Physicians Of Lima Inc 2875 W Elm St Lima OH 45805-2510 Ph: (419) 991-7805 |
| NPI Number | 1134112469 |
|---|---|
| Provider Enumeration Date | 08/23/2005 |
| Last Update Date | 06/11/2014 |
| Medicare PECOS PAC ID | 7719961481 |
|---|---|
| Medicare Enrollment ID | O20040618000092 |
News Archive
Trovagene, Inc. today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.
More than 50 per cent of feverish children are given incorrect doses of medicine by parents and overdoses have almost trebled in the last two decades, according to a research review in the latest issue of the British-based Journal of Advanced Nursing.
Harvard Bioscience, Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the business of Coulbourn Instruments through a purchase of substantially all of Coulbourn's assets.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134112469 | NPI | - | NPPES |
| 1215941711 | Other | OH | NPI# FOR DR. SHARP |
| 0823854 | Medicaid | OH | |
| 1831183896 | Other | OH | NPI# FOR DR. KRENDL |
| 1184619595 | Other | OH | NPI# FOR ELISE CLARK,CNP |
| 1669550182 | Other | OH | GROUP NPI# SATELLITE OFFI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Elise D Clark |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1184619595 PECOS PAC ID: 0345274478 Enrollment ID: I20050919000889 |
News Archive
Trovagene, Inc. today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.
More than 50 per cent of feverish children are given incorrect doses of medicine by parents and overdoses have almost trebled in the last two decades, according to a research review in the latest issue of the British-based Journal of Advanced Nursing.
Harvard Bioscience, Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the business of Coulbourn Instruments through a purchase of substantially all of Coulbourn's assets.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
› Verified 8 days ago
| Provider Name | Karri L Krendl |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1831183896 PECOS PAC ID: 2062496730 Enrollment ID: I20051007000321 |
News Archive
Trovagene, Inc. today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.
More than 50 per cent of feverish children are given incorrect doses of medicine by parents and overdoses have almost trebled in the last two decades, according to a research review in the latest issue of the British-based Journal of Advanced Nursing.
Harvard Bioscience, Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the business of Coulbourn Instruments through a purchase of substantially all of Coulbourn's assets.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
› Verified 8 days ago
| Provider Name | Tracy Lynn Sharp |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1215941711 PECOS PAC ID: 8527077692 Enrollment ID: I20060418000514 |
News Archive
Trovagene, Inc. today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.
More than 50 per cent of feverish children are given incorrect doses of medicine by parents and overdoses have almost trebled in the last two decades, according to a research review in the latest issue of the British-based Journal of Advanced Nursing.
Harvard Bioscience, Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the business of Coulbourn Instruments through a purchase of substantially all of Coulbourn's assets.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
› Verified 8 days ago
| Provider Name | Joel Nicholas Pohlman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235725490 PECOS PAC ID: 1153738075 Enrollment ID: I20210322000182 |
News Archive
Trovagene, Inc. today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.
More than 50 per cent of feverish children are given incorrect doses of medicine by parents and overdoses have almost trebled in the last two decades, according to a research review in the latest issue of the British-based Journal of Advanced Nursing.
Harvard Bioscience, Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the business of Coulbourn Instruments through a purchase of substantially all of Coulbourn's assets.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
› Verified 8 days ago
News Archive
Trovagene, Inc. today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.
More than 50 per cent of feverish children are given incorrect doses of medicine by parents and overdoses have almost trebled in the last two decades, according to a research review in the latest issue of the British-based Journal of Advanced Nursing.
Harvard Bioscience, Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the business of Coulbourn Instruments through a purchase of substantially all of Coulbourn's assets.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
› Verified 8 days ago
Lmpc Specialists At Medpark Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 525 N Eastown Rd Ste A, Lima, OH 45807 Phone: 419-224-4646 Fax: 419-224-2410 | |
Pierson Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1220 E Elm St, Ste 240, Lima, OH 45804 Phone: 419-227-9676 Fax: 419-227-9794 | |
Physicians Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 750 W High St, Suite 250, Lima, OH 45807 Phone: 419-227-7399 Fax: 419-229-0123 | |
Lmp Concussion Management Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 345 S Elizabeth St, Lima, OH 45801 Phone: 419-226-5075 Fax: 419-998-4586 | |
In House Internists, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 750 W High St, Suite 200, Lima, OH 45801 Phone: 419-229-2622 | |
Mercy Health Physicians Lima Specialty Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 770 W High St Ste 450, Lima, OH 45801 Phone: 419-996-5078 | |
Dr. Suman K. Mishr M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 830 W High St, Su. 380, Lima, OH 45801 Phone: 419-996-5240 |